Diazepam binding inhibitor

DBI
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesDBI, ACBD1, ACBP, CCK-RP, EP, Diazepam binding inhibitor, diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein), diazepam binding inhibitor, acyl-CoA binding protein
External IDsOMIM: 125950; MGI: 94865; HomoloGene: 39086; GeneCards: DBI; OMA:DBI - orthologs
Orthologs
SpeciesHumanMouse
Entrez

1622

13167

Ensembl

ENSG00000155368

ENSMUSG00000026385

UniProt

P07108

P31786

RefSeq (mRNA)

NM_001037999
NM_007830

RefSeq (protein)

NP_001033088
NP_031856

Location (UCSC)Chr 2: 119.37 – 119.37 MbChr 1: 120.04 – 120.05 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Acyl-CoA-binding protein in humans belongs to the family of Acyl-CoA-binding proteins.

This gene encodes diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. The protein is conserved from yeast to mammals, with the most highly conserved domain consisting of seven contiguous residues that constitute the hydrophobic binding site for medium- and long-chain acyl-Coenzyme A esters. Diazepam binding inhibitor also mediates the feedback regulation of pancreatic secretion and the postprandial release of cholecystokinin, in addition to its role as a mediator in corticotropin-dependent synthesis of steroids in the adrenal gland. Three pseudogenes located on chromosomes 6, 8 and 16 have been identified. Multiple transcript variants encoding different isoforms have also been described for this gene.